The impact of data errors on the outcome of randomized clinical trials.

about

The impact of data errors on the outcome of randomized clinical trials.

Item

http://www.wikidata.org/entity/Q36412734

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The impact of data errors on the outcome of randomized clinical trials.

@ast

The impact of data errors on the outcome of randomized clinical trials.

@en

type

Item

label

The impact of data errors on the outcome of randomized clinical trials.

@ast

The impact of data errors on the outcome of randomized clinical trials.

@en

prefLabel

The impact of data errors on the outcome of randomized clinical trials.

@ast

The impact of data errors on the outcome of randomized clinical trials.

@en

P1476

The impact of data errors on the outcome of randomized clinical trials.

@en

P2093

Cornelis Ja Punt

http://www.w3.org/2001/XMLSchema#string

Elisabeth Coart

http://www.w3.org/2001/XMLSchema#string

Everardo D Saad

http://www.w3.org/2001/XMLSchema#string

Pierre Squifflet

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer

The value of source data verification in a cancer clinical trial.

Data fraud in clinical trials.

Ensuring trial validity by data quality assurance and diversification of monitoring methods.

Improving the quality of drug research or simply increasing its cost? An evidence-based study of the cost for data monitoring in clinical trials.

A statistical approach to central monitoring of data quality in clinical trials.

Bias due to misclassification in the estimation of relative risk.

Lessons learned from independent central review.

Review of oncology and hematology drug product approvals at the US Food and Drug Administration between July 2005 and December 2007.

P304

1740774517716158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1740774517716158

http://www.w3.org/2001/XMLSchema#string

P50

Marc Buyse

Emmanuel Quinaux

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28641461

http://www.w3.org/2001/XMLSchema#string